Copyright
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Feb 6, 2017; 8(1): 67-73
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.67
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.67
Table 2 Estimation of non-adherence levels by respondents and percentage in line with evidence
| Medication | Column A: literature-based non-adherence levels | Column B: perceived mean non-adherence levels | Proportion who estimated non-adherence levels below the levels in column A |
| Mesalazine | 30%-45% | 20% | 31% |
| Immunomodulator therapy | 15%-20% | 10% | 28% |
| Biological agents | 5%-10% | 1% | 23% |
- Citation: Soobraty A, Boughdady S, Selinger CP. Current practice and clinicians’ perception of medication non-adherence in patients with inflammatory bowel disease: A survey of 98 clinicians. World J Gastrointest Pharmacol Ther 2017; 8(1): 67-73
- URL: https://www.wjgnet.com/2150-5349/full/v8/i1/67.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i1.67